Business UpdateJun 1, 2026, 05:24 PM
Helus Pharma CEO to Speak at Jefferies Global Healthcare Conference
AI Summary
Helus Pharma announced that its Interim Chief Executive Officer, Eric So, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York. The event is scheduled for June 4, 2026, at 2:35 p.m. EDT, and will be webcast live. Helus Pharma, operating as Cybin Inc., is a clinical-stage pharmaceutical company focused on developing novel serotonergic agonists for mental health conditions.
Key Highlights
- Helus Pharma Interim CEO Eric So to participate in a fireside chat.
- The event is the Jefferies Global Healthcare Conference in New York.
- Fireside chat scheduled for Thursday, June 4, 2026, at 2:35 p.m. EDT.
- A live webcast and replay will be available on Helus Pharma's investor relations website.
- Helus Pharma is a clinical-stage pharmaceutical company developing novel serotonergic agonists (NSAs).
- The company is developing HLP003 (Phase 3 for MDD) and HLP004 (Phase 2 for GAD).
Price Impact
More from HELP